Skip to main content

Table 1 Urinary ADAM 12 of cancer patient group vs. control group

From: Urinary concentrations of ADAM 12 from breast cancer patients pre- and post-surgery vs. cancer-free controls: a clinical study for biomarker validation

  Cancer group: pre-surgery Cancer group: post-surgery Control group
  (n = 50) (n = 49) (n = 46)
Age Mean: 60.9 ± 13.0 Mean: 60.9 ± 13.0 Mean: 60.1 ± 12.4
Median: 60 Median: 60 Median: 60
[ADAM 12] (ng/mL) Mean: 3.36 ± 3.04 Mean: 16.3 ± 15.6 Mean: 3.52 ± 3.17
Median: 2.48 Median: 10.3 Median: 2.77
Total protein (μg/mL) Mean: 60.7 ± 53.6 Mean: 59.7 ± 32.9 Mean: 78.6 ± 65.6
Median: 42.0 Median: 59.0 Median: 58.7
ADAM 12 as % of total protein Mean: 0.008 ± 0.01 Mean: 0.03 ± 0.03 Mean: 0.006 ± 0.006
  Median: 0.005 Median: 0.017 Median: 0.004
  1. Cancer group consists of DCIS (n = 15) and IBC (n = 35) diagnoses.